Cypress Capital Group Pfizer Inc Transaction History

Cypress Capital Group

$879 Million
Q3 2024

A detailed history of Cypress Capital Group transactions in Pfizer Inc stock. As of the latest transaction made, Cypress Capital Group holds 121,314 shares of PFE stock, worth $3.22 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

121,314

Previous 118,118 2.71%

Holding current value

$3.22 Million

Previous $3.3 Million 6.23%

% of portfolio

0.4%

Previous 0.4%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$27.7 - $31.39 $88,529 - $100,322	3,196 Added 2.71%	121,314 $3.51 Million
Q2 2024 Jul 25, 2024	SELL	$25.26 - $29.6 $392,489 - $459,924	-15,538 Reduced 11.63%	118,118 $3.3 Million
Q1 2024 May 08, 2024	BUY	$25.89 - $29.73 $324,091 - $372,160	12,518 Added 10.33%	133,656 $3.71 Million
Q4 2023 Jan 24, 2024	BUY	$26.13 - $33.94 $211,653 - $274,914	8,100 Added 7.17%	121,138 $3.49 Million
Q3 2023 Nov 02, 2023	BUY	$32.09 - $37.51 $74,192 - $86,723	2,312 Added 2.09%	113,038 $3.75 Million
Q2 2023 Jul 26, 2023	SELL	$36.12 - $41.79 $1.25 Million - $1.44 Million	-34,488 Reduced 23.75%	110,726 $4.06 Million
Q1 2023 May 04, 2023	BUY	$39.39 - $51.28 $53,688 - $69,894	1,363 Added 0.95%	145,214 $5.92 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $213,593 - $278,822	5,116 Added 3.69%	143,851 $7.37 Million
Q3 2022 Nov 04, 2022	BUY	$43.76 - $53.42 $798,882 - $975,235	18,256 Added 15.15%	138,735 $6.07 Million
Q2 2022 Jul 26, 2022	BUY	$46.53 - $55.17 $144,149 - $170,916	3,098 Added 2.64%	120,479 $6.32 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $840,839 - $1.04 Million	18,379 Added 18.56%	117,381 $6.08 Million
Q4 2021 Feb 15, 2022	BUY	$41.32 - $61.25 $591,454 - $876,732	14,314 Added 16.9%	99,002 $5.85 Million
Q3 2021 Oct 12, 2021	SELL	$39.25 - $50.42 $9,773 - $12,554	-249 Reduced 0.29%	84,688 $3.64 Million
Q2 2021 Jul 13, 2021	BUY	$35.91 - $40.68 $532,078 - $602,755	14,817 Added 21.13%	84,937 $3.33 Million
Q1 2021 Apr 14, 2021	SELL	$33.49 - $37.77 $128,132 - $144,508	-3,826 Reduced 5.17%	70,120 $2.54 Million
Q4 2020 Jan 12, 2021	BUY	$33.47 - $42.56 $71,625 - $91,078	2,140 Added 2.98%	73,946 $2.72 Million
Q3 2020 Oct 08, 2020	SELL	$31.75 - $37.25 $247,205 - $290,028	-7,786 Reduced 9.78%	71,806 $2.64 Million
Q2 2020 Jul 10, 2020	BUY	$30.12 - $36.54 $528,425 - $641,057	17,544 Added 28.27%	79,592 $2.6 Million
Q1 2020 Apr 08, 2020	SELL	$27.03 - $38.62 $389,475 - $556,475	-14,409 Reduced 18.85%	62,048 $2.03 Million
Q4 2019 Jan 10, 2020	SELL	$32.92 - $37.36 $249,566 - $283,226	-7,581 Reduced 9.02%	76,457 $3 Million
Q3 2019 Oct 10, 2019	SELL	$32.49 - $42.13 $257,093 - $333,374	-7,913 Reduced 8.61%	84,038 $3.02 Million
Q2 2019 Aug 15, 2019	SELL	$36.98 - $41.52 $16,012 - $17,978	-433 Reduced 0.47%	91,951 $3.98 Million
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $60,450 - $66,414	-1,612 Reduced 1.71%	92,384 $3.92 Million
Q4 2018 Feb 19, 2019	SELL	$38.47 - $43.86 $25,082 - $28,596	-652 Reduced 0.69%	93,996 $4.1 Million
Q3 2018 Nov 15, 2018	SELL	$34.47 - $41.81 $14,408 - $17,476	-418 Reduced 0.44%	94,648 $4.17 Million
Q2 2018 Aug 15, 2018	SELL	$32.98 - $35.16 $306,911 - $327,198	-9,306 Reduced 8.92%	95,066 $3.45 Million
Q1 2018 May 21, 2018	BUY	$31.91 - $37.02 $93,496 - $108,468	2,930 Added 2.89%	104,372 $3.7 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $88,571 - $93,977	2,663 Added 2.7%	101,442 $3.67 Million
Q3 2017 Nov 16, 2017	SELL	$31.0 - $34.15 $481,895 - $530,861	-15,545 Reduced 13.6%	98,779 $3.53 Million
Q2 2017 Aug 15, 2017	BUY	N/A	114,324	114,324 $3.84 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Capital Group, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Capital Group with notifications on news.

Account

Cypress Capital Group Pfizer Inc Transaction History